4DMedical Ltd
ASX:4DX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2.7), the stock would be worth AU$-0.15 (103% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -86 | AU$4.76 |
0%
|
| 3-Year Average | 2.7 | AU$-0.15 |
-103%
|
| 5-Year Average | 3.1 | AU$-0.17 |
-104%
|
| Industry Average | 3.3 | AU$-0.18 |
-104%
|
| Country Average | 2.7 | AU$-0.15 |
-103%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
4DMedical Ltd
ASX:4DX
|
2.5B AUD | -86 | -14.8 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 20.7 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 8 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.4B USD | 3.7 | 29 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.5B AUD | 37.2 | 61.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 2.6 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
51.8B SEK | 26.8 | 96.4 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 1.2 | 42.4 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 4.5 | 18.6 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.3B CNY | 3.4 | -62.7 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 17.2 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.3 |
| Max | 2 199.4 |
Other Multiples
4DMedical Ltd
Glance View
4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.
